• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Vaccines . Immunodominant antibodies against hemagglutinin in ferrets following infection with 2018 to 2019 influenza vaccine strains

tetano

Editor, Senior Moderator
NPJ Vaccines


. 2025 Nov 21.
doi: 10.1038/s41541-025-01282-y. Online ahead of print. Immunodominant antibodies against hemagglutinin in ferrets following infection with 2018 to 2019 influenza vaccine strains

Zhu Guo[SUP] 1 [/SUP], Thomas Rowe[SUP] 2 [/SUP], Jessie Chang[SUP] 2 [/SUP], Paul J Carney[SUP] 2 [/SUP], John Steel[SUP] 2 [/SUP], James Stevens[SUP] 3 [/SUP]



Affiliations
Abstract

Global influenza surveillance depends on antigenic characterization of viral isolates through hemagglutination inhibition and microneutralization assays using sera from panels of ferrets, each infected with a single vaccine virus. However, recent studies have revealed limitations in ferret-based antigenic analyses. Therefore, a deeper understanding of ferret antibody responses following viral infection is essential for better evaluation and interpretation of antigenicity data derived from ferret sera. This study utilized a biolayer interferometry (BLI)-based binding assay and panels of recombinant hemagglutinin (rHA1), each carrying multiple substitutions within one of the antigenic sites of H1 or H3 HA, to analyze the immunodominant antibodies against HA in ferret sera following infection with the 2018-2019 Northern Hemisphere influenza vaccine virus A/Michigan/45/2015(H1N1)pdm09 (MI/45) or A/Singapore/INFIMH-16-0019/2016(H3N2) (SING/16). The results demonstrate dominant antibody responses against HA in ferrets and provide valuable insights into interpreting ferret-derived antigenicity data and improving influenza vaccine virus selection.


 
Back
Top Bottom